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Abstract
Although taurine and glutamate are the most abundant amino acids conducting neural signals in the central ner-
vous system, the communication between these two neurotransmitters is largely unknown. This study explores the
interaction of taurine and glutamate in the retinal third-order neurons. Using specific antibodies, both taurine and
taurine transporters were localized in photoreceptors and Off-bipolar cells, glutamatergic neurons in retinas. It is
possible that Off-bipolar cells release juxtaposed glutamate and taurine to activate the third-order neurons in
retina. The interaction of taurine and glutamate was studied in acutely dissociated third-order neurons in whole-
cell patch-clamp recording and Ca
2+ imaging. We find that taurine effectively reduces glutamate-induced Ca
2+
influx via ionotropic glutamate receptors and voltage-dependent Ca
2+ channels in the neurons, and the effect of
taurine was selectively inhibited by strychnine and picrotoxin, but not GABA receptor antagonists, although GABA
receptors are present in the neurons. A CaMKII inhibitor partially reversed the effect of taurine, suggesting that a
Ca
2+/calmodulin-dependent pathway is involved in taurine regulation. On the other hand, a rapid influx of Ca
2+
through ionotropic glutamate receptors could inhibit the amplitude and kinetics of taurine-elicited currents in the
third-order neurons, which could be controlled with intracellular application of BAPTA a fast Ca
2+ chelator. This
study indicates that taurine is a potential neuromodulator in glutamate transmission. The reciprocal inhibition
between taurine and glutamate in the postsynaptic neurons contributes to computation of visual signals in the
retinal neurons.
Introduction
Taurine is a sulfur containing amino acid structurally
similar to the neurotransmitters glycine and GABA
(Gamma aminobutyric acid). It is the most abundant
free amino acid in retina and the second most abundant
free amino acid in the central brain after glutamate [1].
Although taurine has been found to play a large role in
neural development, osmoregulation and neural protec-
tion, the function of taurine in neurotransmission and
modulation remains poorly understood. In many studies
taurine has been considered as a low affinity ligand
binding to glycine or GABA receptors [2,3]. Yet, studies
also indicate that taurine-produced effects can not be
simply repeated by either glycine or GABA [4-6]. The
absence of any molecular evidence of a specific receptor
and a lack of a specific antagonist for taurine make it
difficult to differentiate its effects from glycine and
GABA. Taurine is known to have its own transporters
expressed in both neurons and astroglial cells [7] and in
many cases, taurine transporters are found in glutama-
tergic neurons, suggesting that taurine and glutamate
may be released from the same neurons. This feature in
general is distinct from glycine and GABA that are
released from the neurons other than glutamatergic
cells.
Glutamate is the major excitatory neurotransmitter
conducting visual signals within retina. In general gluta-
mate releases from presynaptic neurons and transmits
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receptors in the postsynaptic neurons. Activation
of metabotropic receptors usually triggers intra-
cellular transduction pathways associated with changes
of [Ca
2+]i levels, leading to a large amplification of gluta-
mate signals; whereas activation of ionotropic receptors
directly changes the cell membrane potential by cation
influx. Some ionotropic glutamate receptors are Ca
2+
permeable. Ca
2+ entrance triggers intracellular second-
messenger pathways that lead to alterations in cellular
and molecular levels in neurons. Therefore regulation of
Ca
2+ permeable glutamate receptors in neurons can
exert a large influence in neuronal signals. This study is
to examine the effect of taurine on regulation of Ca
2+
permeable ionotropic glutamate receptors in the retinal
neurons.
In retinas, taurine is primarily found in the glutama-
tergic neurons, photoreceptors and bipolar cells of rat
[8], goldfish [9-11] and Cynomologous monkey [12].
Taurine uptake has been also observed in amacrine and
ganglion cells, as well as non-neurons, Müller cell and
pigmentary epithelium cells, in the early developmental
and young ages of animals [13-16]. Since amacrine and
ganglion cells receive glutamate inputs from bipolar
cells, as well as glycine and GABA inputs from sur-
rounding amacrine cells if taurine is released from bipo-
lar cells, it would juxtapose with these neurotransmitters
on amacrine and ganglion cells. Because ganglion cells
convey retinal neural signals to the brain via optic
nerves, the balance between the excitatory and inhibi-
t o r ys i g n a l si nt h en e u r o n si sc r i t i c a lf o rv i s u a ls i g n a l
processing from retina to the central brain. The effect of
taurine in regulation of glutamate signals in ganglion
cells has not yet been determined.
We used amphibian retinal amacrine and ganglion
cells, the third-order neurons, as a model system to
study the interactions of taurine and glutamate signals.
To avoid retinal network effects, isolated neurons were
used in this study. We characterized taurinergic neurons
using specific antibodies against taurine and the taurine
transporter. The results indicate that photoreceptors
and Off-type bipolar cells are taurinergic neurons in the
retina. We find that the effect of taurine on the third-
order neurons suppresses Ca
2+ influx through both
ionotropic glutamate receptors and voltage-gated Ca
2+
channels. Taurine regulation of ionotropic glutamate
receptors was dose-dependent and via a Ca
2+ sensitive
calmodulin kinase II (CaMKII) intracellular pathway and
the contribution of protein kinase A (PKA) to a lesser
extent. On the other hand, taurine-elicited responses
were effectively reduced by rapid [Ca
2+]i increase via
AMPA and kainate receptors in the third-order neurons.
The effects of taurine and glutamate reciprocally inhibit
each other, linked by [Ca
2+]i. Our study indicates that
taurine is important for control of glutamate-induced
Ca
2+ overload in the retinal third-order neurons.
Materials and methods
Cell dissociation
Larval tiger salamanders (Ambystoma tigrinum), were
purchased from Kons Scientific (Germantown, WI) and
Charles Sullivan (Nashville, TN). The animals were kept
in aquaria at a constant 12
oC under a 12-hour dark-
light cycle with continuous filtration. The retinas were
collected from animals that had been kept at least six
hours in the dark. Briefly, the animals were decapitated,
double-pithed and the eyes were enucleated. All proce-
dures were performed in accordance with the guidelines
of National Institutes of Health Guide for the Care and
Use of Laboratory Animals and approved by the Univer-
sity’s Animal Care Committee.
The retinal tissue was removed from the eyecup in
Ringer’s solution consisting of (in mM):111 NaCl, 2.5
KCl, 1.8 CaCl2,1M g C l 2,5H E P E Sa n d1 0D e x t r o s e ,
adjusted to pH = 7.7. Retinal tissue was then dissociated
in freshly prepared enzymatic tissue dissociation solu-
tion containing 50μl papain (12 Uml
-1), 400μlo fR i n g -
er’s solution containing (in mM) 5 L-Cysteine and 1
EDTA (adjusted to pH 7.4) for 20-35 minutes at room
temperature. The enzymatically treated retina was
washed before being mechanically dissociated, by gentle
shaking, in Ringer’s solution. The dissociated cells were
seeded on 18mm glass cover slips freshly coated with
lectin and allowed to set for 20 minutes before use. The
cover slip was then placed in the recording chamber
containing Ringer solution on an Olympus BX51WI
microscope equipped with a CCD camera linked to a
monitor. All experimentation was done at room tem-
perature and within a few hours of preparation.
Electrophysiological recording system
Whole-cell recordings were performed on amacrine and
ganglion cells using an EPC-10 amplifier and HEKA
Patchmaster software. These third-order neurons were
identified based on their distinctive large transient
sodium currents for whole cell recording. Low resistance
(5-10MΩ) electrodes were pulled from borosilicate glass
(Drummond Scientific Co) with the P-97 micropipette
puller (Sutter Instrument Co). The electrodes were filled
with a high-potassium solution containing (in mM): 100
K-gluconate, 1 MgCl2, 5 EGTA and 10 HEPES, with an
ATP regenerating cocktails consisting of (in mM): 20
ATP, 40 Phosphocreatine and 2 Creatine Phosphokinase
(adjusted to pH 7.4). Cell responses were recorded at a
holding potential of -60mV.
The isolated cell preparation was constantly perfused
with oxygenated Ringer’s solution. A DAD-VM auto-
mated superfusion system (ALA Scientific Instruments)
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AMPA and kainic acid with or without Taurine pre-per-
fusion were all applied for 3-second intervals. Any
antagonist that was also applied during experimentation
was first pre-perfused at a low pressure. All drugs were
prepared in stock solutions before being diluted to their
final concentrations (listed in results section) in the per-
fusion solution on the day of use.
Immunocytochemistry
Freshly enucleated eyeballs were fixed in either 2.25%
glutaraldehyde with 2% paraformaldehyde (for anti-taur-
ine labeling) or 4% paraformaldehyde (for anti-taurine
transporter labeling) in Ringer’s solution for 10 minutes,
before 10 minutes fixation of the eyecups after corneas
were removed. The eyecups were then thoroughly
washed in the Ringer’s solution. The fixed eyecups were
gradually dehydrated in 15%, 20% and then 30% sucrose
solutions (in the Ringer’s solution) before being kept
overnight in 30% sucrose. The eyecups were embed in
the optimal cutting temperature (OCT) compound (Ted
Pella, Redding CA), frozen and dissected at 12-20µm
thickness. The frozen sections were collected on silane
coated slides, dried and stored at -80°C.
Retinal frozen sections were rinsed with PBS and trea-
ted with an antibody blocking reagent “cocktail” consist-
ing of 10% goat serum, 1% BSA in 0.3% Triton X-100
with 0.1% Tween in PBS (PBST) for 20 minutes. The
retinal sections were then incubated with an affinity
purified rabbit anti-taurine polycolonal antibody (Lot:
LV1503470, Chemicon), with a 1:200 concentration, or
rabbit anti-taurine transporter polyclonal antibody (Lot:
LV1390267, Chemicon) with 10µg/mL for 2 hours. After
being washed for 35 minutes, the sections were incu-
bated with a secondary antibody, the goat-anti-rabbit
Cy-3-conjugated (1:600) antibody for 40 minutes in a
dark room. The retinal sections were rinsed with PBS
and were mounted with Vectorshield (Vector Labora-
tories, Burlingame, CA). A Zeiss LSM 700 confocal
microscope system was used to observe fluorescence
labeling in the retinal sections. Single scanning and mul-
tiple scanning along Z-direction were applied on the
sections with the Zen software. The images were col-
lected and processed with the software.
Ca
2+ imaging
Isolated retinal cells seeded on lectin-coated cover slips
were incubated for 20-25 minutes in the cell-permeable
calcium sensitive Fluo-4 AM dye (3μMi nr i n g e rs o l u -
tion). The cover slip was washed in Ringer’ss o l u t i o n
before being placed in the recording chamber. Cells
were excited at 480nm with the emission collected at
520nm. A Rolera-MGi Plus camera (Q-imaging) was
used to view and collect fluorescence signals. Frame
images were taken every 3 seconds with cells exposed
for 50 milliseconds at each interval. A Lambda 10-2
(Sutter Instrument Co) controlled by IP Lab 4.0 soft-
ware was used to open and close the filter shutter at
each interval. All cell preparation and experimentation
was done at room temperature in complete darkness.
The third-order neurons were identified by their mor-
phology. Usually, dissociated ganglion cells appeared to
have a long axon process extending from the cell somas;
the dissociated amacrine cells have larger somas than
that of bipolar cells. However, with the morphological
profiles, we could not rule out the possibility that some
bipolar and horizontal cells might be mistakenly
counted in our experiments since most of dissociated
cells lost their clear morphology.
Data analysis
Electrophysiological data was obtained using HEKA
Patchmaster software and analyzed using Igor Pro
Software. Ca
2+ imaging data was measured using IP
L a b4 . 0s o f t w a r e .I nt h e s ee x p e r i m e n t si n d i v i d u a l
frames from a single experiment were combined into
sequences before specific regions of interest were
selected. For each cell in each sequence that showed a
response the intensity value was normalized by first
subtracting the baseline value before dividing by the
maximum intensity for that cell. The normalized
values for each experiment set were then combined to
produce a mean value trace. Mean, Standard Error and
paired t-test values were all calculated using Microsoft
Office 2007.
Chemicals
Taurine, Glycine, L-Glutamic acid, Lectin from Triticum
vulgaris, Picrotoxin, Potassium D-gluconate, K-gluco-
nate, BAPTA, EGTA, Adenosine 5′-Triphosphate (ATP),
Phosphocreatine, Creatine Phosphokinase Type I, CoCl2,
NaCl and Dextrose were purchased from Sigma-Aldrich
Inc (St Louis, MO). L-Cysteine, EDTA, HEPES, MgCl2
and KCl were purchased from J.T. Baker (Phillipsburg,
NJ). CaCl2 was purchased from Fisher Scientific (Fair
Lawn, NJ). Papain and Deoxyribonuclease I were pur-
chased from Worthington Biochemical (Lakewood, NJ).
K a i n i cA c i d ,( S ) - A M P A ,N M D A ,S R9 5 5 3 1 ,B i c u c u l l i n e ,
TPMPA, CGP 55845, GF 10920X, H-7, H-89, KN-62,
PKI 14-22 amide, Thapsigargin, Ruthenium Red, CNQX
and L-AP7 were all purchased from Tocris Bioscience
(Ellisville, MO). Fluo-4AM was purchased from Invitro-
gen Corporation (Carlsbad, CA).
Results
Taurine-containing neurons in the amphibian retina
The taurine-positive neurons in tiger salamander retina
were labeled by the specific antibody of taurine in
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cytochemical results, indicating that the anti-taurine
labeling was present in the somas and processes of
rods and a few cones, as well as in the displaced bipo-
lar cells located in the outer nuclear layer (see aster-
isks). Displaced bipolar cells in the outer nuclear layer
(ONL) of salamander retina have been characterized as
Off-type bipolar cells in a previous study [56]. The
anti-taurine labeling was also present in the bipolar
cell somas in the inner nuclear layer (INL) and the
processes at the distal half of the inner plexiform layer
(IPL). In contrast, no taurine antibody labeling was
observed in the proximal half of the IPL. It is known
that the axon terminals of On- and Off-bipolar cells in
Figure 1 Taurinergic neurons and taurine–dose response in salamander retina. Immunoreactive pattern shows that taurine labeling is
present in rods, a few cones and displaced Off-bipolar cells (asterisks) in the ONL. It is also present in cell somas in the INL and axon terminals
in the sublamina of the IPL (A); anti-taurine transporter labels rod axons and Off-bipolar cell axons in the sublamina a of the IPL (B). Whole-cell
recording of taurine dose response currents from an isolated ganglion cell (C). Taurine dose-response curve and EC50 value were obtained from
the third-order neurons.
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mal and distal half of the IPL respectively, therefore
the taurine-positive labeling in the distal IPL indicates
that Off-bipolar terminals may contain taurine. The
taurine antibody-labeling results indicated that both
amacrine and ganglion cell somas were taurine nega-
tive in salamander retina.
To further characterize taurinergic neurons, a specific
taurine transporter antibody was used. Figure 1B shows
transporter antibody labeled photoreceptor axones and
some processes at the distal sublamina of the IPL in ret-
inal sections (see arrows). The result of taurine trans-
porter labeling was consistent with taurine labeling
further indicating that Off-bipolar cells might be tauri-
nergic neurons releasing taurine. As Off-bipolar cells are
also glutamatergic neurons, our results suggest that
these neurons might release both glutamate and taurine.
Therefore, amacrine and ganglion cells as the third-
order neurons receive juxtaposed inputs of glutamate
and taurine in the IPL.
Taurine dose responses in isolated third-order neurons
To study the sensitivity of taurine, taurine dose-depen-
dent currents were studied in dissociated third-order
neurons in whole-cell voltage-clamp mode. The cells
were identified by their electrical properties with vol-
tage-dependent Na
+ currents in multiple depolarizing
voltage steps. Photoreceptors, bipolar cells and hori-
zontal cells were lacking Na
+ currents, enabling the
third-order neurons in isolated cell preparations to be
distinguished. Third-order neurons can be further
characterized as Na
+ currents are much smaller in
amacrine cells compared to those in ganglion cells.
The cells were voltage-clamped at -70mV, near the
resting potential of the cells. Inward currents were
recorded from the cells elicited with taurine concentra-
tions of 10µM, 20µM, 50µM, 100µM, 500µM, 1mM.
2mM and 4mM puffed locally on the neurons. Figure
1C shows typical taurine currents elicited by various
concentrations recorded from ganglion cells. The
amplitudes of taurine currents were measured and
plotted as a dose response relationship curve (Fig. 1D),
showing that 10µM taurine elicited a negligible current
with maximum currents elicited by 2mM taurine. A
taurine concentration of 330µM elicited a half maxi-
mum response (EC50) determined from the dose
response relationship curve (see dot-lines, Fig. 1D).
T a u r i n ed o s er e s p o n s ec u r r e n t sa l s oi n d i c a t et h a tc o n -
centrations of taurine below the EC50 value elicit sus-
tained inward currents with limited desensitization.
Transient currents with fast desensitization were
observed when the concentration was higher than the
EC50,a ss h o w ni nf i g u r e1 C .
Taurine suppressed glutamate-induced [Ca
2+]i in the
third-order neurons
The effect of taurine on glutamate response was studied
in the third-order neurons using Ca
2+ imaging. The
isolated cells were loaded with a membrane permeable
Ca
2+ indicator Fluo-4-AM. The third-order neurons
were identified by their morphology (see the Methods
section). Application of 200µM glutamate evoked a large
[Ca
2+]i increase from the third-order neurons. When
taurine was co-applied with glutamate in 10µM, 350µM
and 2mM, the minimum, EC50 and maximum concen-
trations respectively, the [Ca
2+]i was suppressed in a
dose-dependent manner.F i g u r e2 As h o w st h e[ C a
2+]i
changes in the third-order neurons activated by gluta-
mate and glutamate with varying concentrations of taur-
ine. On average, 10µM taurine reduced 23% of
glutamate-elicited free [Ca
2+]i levels, with the EC50 and
maximum concentration of taurine blocking 40% and
67% of the glutamate-elicited free [Ca
2+]i respectively in
the third-order neurons (n=40). This indicates that the
effect of taurine effectively suppressed glutamate-elicited
[Ca
2+]i in the neurons.
As glutamate activates kainate-, AMPA- and NMDA-
sensitive ionotropic receptors, we used the receptor ago-
nists to separate activity at each single receptor subtype.
Previous Ca
2+ imaging studies indicate that low concentra-
tions of kainate and AMPA specifically activate their own
receptors that are highly permeable to Ca
2+ in the third-
order neurons [17]. Kainate and AMPA at concentrations
of 15µM increased [Ca
2+]i in the neurons (Fig. 2B &2C).
10µM taurine reduced AMPA-induced [Ca
2+]i to 80% of
the control (n=72), but had no significant effect on
kainate-induced [Ca
2+]i with no reduction in the level of
[Ca
2+]i (n=23). This indicates that the low concentration
of taurine selectively suppressed AMPA-sensitive receptor
response in the neurons. Higher taurine concentrations
gradually suppressed AMPA-induced [Ca
2+]i, but acutely
reduced kainate-induced [Ca
2+]i in the neurons (Fig. 2B
and 2C). Kainate-induced [Ca
2+]i, but not AMPA-induced
[Ca
2+]i, was completely blocked by 2mM taurine. Since
AMPA receptors, but not kainate receptors, are synaptic
in the third-order neurons [18], the different effects of
taurine on AMPA and kainate responses suggest that taur-
ine might have alternate functions on synaptic and non-
synaptic glu tamate receptors. The effect of taurine on
NMDA receptors was also examined in the third-order
neurons. On average, 10µM and 350µM taurine sup-
pressed 29% and 77% of NMDA-induced [Ca
2+]i in the
neurons, respectively (n=27). NMDA-induced [Ca
2+]i was
completely blocked by 2mM taurine (Fig. 2D).
Taken together, these results indicate that taurine at
higher concentrations from 350µM to 2mM could effec-
tively block Ca
2+-permeable kainate and NMDA
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2+ -permeable
AMPA receptors.
The effect of taurine was sensitive to strychnine and
picrotoxin, but not GABA receptor antagonists
As the third-order neurons possess both glycine and
GABA receptors, the effect of taurine on suppression of
glutamate-induced [Ca
2+]i was examined with the addition
of various glycine and GABA receptors antagonists. Figure
3A shows that 2mM taurine suppressed glutamate-
induced [Ca
2+]i by 55% (t=17.21, df=136, p<0.0001), which
was significantly reversed by 2µM strychnine to 75% of the
control (t=6.44, df=136, p<0.0001). The remaining strych-
nine-insensitive effect indicates that taurine might activate
different types of receptors. The effect of taurine on
AMPA- and kainate-induced [Ca
2+]i in the third-order
neurons was also tested. In the control, 2mM taurine sig-
nificantly suppressed both 15µM AMPA- by 65% (t=15.78,
df=82, p<0.0001) and 15µM kainate-induced [Ca
2+]i by
85% (t=19.65, df=52, p<0.0001) in the third-order neurons,
as shown in figure 3B and 3C. Though strychnine
appeared to be more effective on blocking the effect of
taurine on AMPA-induced [Ca
2+]i compared to kainate-
induced [Ca
2+]i, the reversal was significant for both
AMPA (from 35% to 85%; t=9.4488, df=82, p<0.0001) and
kainate (from 15% to 60%; t= 5.52, df=52, p<0.0001).
These results suggest that the action of taurine on gluta-
mate receptors could therefore be mediated by strychnine-
sensitive receptors.
The effect of strychnine could be duplicated
by 100µM picrotoxin, a non-selective blocker for Cl
-
permeable receptors, including both glycine and GABA
Figure 2 Statistical results of taurine regulation of glutamate-induce [Ca
2+]i in isolated third-order neurons. Taurine suppresses the [Ca
2
+]i in the third-order neurons in a dose- dependent manner (A). Suppressive effects of taurine on AMPA-, kainate- and NMDA-induced [Ca
2+]i in
the neurons (B, C and D).
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effects of taurine on glutamate-, AMPA- and kainate-induced [Ca
2+]i from the third-order neurons (A, B and C). Picrotoxin (100µM) had similar
effects as strychnine partially reversing the effects of taurine on glutamate- and AMPA-induced [Ca
2+]i (D and E).
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the effect of 2mM taurine on glutamate-induced [Ca
2+]i
from 55% to 30% (t=3.93, df=96, p = 0.0002), showing
in figure 3D. Picrotoxin was more effective in blocking
the taurine effect on AMPA-induced [Ca
2+]i.F i g u r e3 E
shows that in control taurine suppressed about 70% of
AMPA-induced response; with picrotoxin taurine having
20% suppression on the AMPA-induced response
(t=12.18, df=64, p<0.0001). This indicates that the effect
of taurine on glutamate-induced [Ca
2+]i is active
through a Cl
- permeable receptor blocked by picrotoxin.
The effect of picrotoxin and strychnine was not repli-
cated by GABA receptor antagonists that had no
significant effect on taurine suppression of glutamate-
induced [Ca
2+]i. Figure 4A and 4B show that both
GABAA receptor antagonists, 10µM bicuculline (t=0.89,
df=98, p=0.375) and 20µM SR95531 (t=0.59, df=80,
p=0.5642) had no significant effect on reversing taurine-
produced suppression on glutamate-induced [Ca
2+]i .I n
addition the GABAC receptor antagonist 50µM TPMPA
(t=0.26, df=70, p=0.7913) and the GABAB receptor
antagonist 10µM CGP55845 (t=0.77, df=82, p=0.4422)
were also unable to reverse taurine-produced suppres-
sion (Fig. 4C and 4D). These results clearly show that
the effect of taurine was unrelated to all GABA receptor
subtypes.
Figure 4 GABA receptor antagonists had no effect on taurine-produced effects. Neither GABAA receptor antagonists, bicuculline (10µM)
and SR95531 (10µM) (A and B), nor GABAC and GABAB receptor antagonists, TPMPA (50µM) and CGP55845 (10µM; C and D) block taurine
suppression on glutamate-induced [Ca
2+]i .
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2+]i in the third-order neurons
could be the result of activation of both metabotropic
and ionotropic receptors. Therefore to separate their
individual effects, CNQX (6-cyano-7-nitroquinoxaline-
2,3-dione) and AP-7 (D,L-2-amino-7-phosphonohepta-
noic acid) were used to block all ionotropic glutamate
receptors. The glutamate-induced [Ca
2+]i was comple-
tely blocked by the presence of these ionotropic
glutamate receptor antagonists, and in addition when
2mM taurine was co-applied it had no effect on [Ca
2+]i
in the neurons (Fig. 5A), suggesting that activation of
ionotropic glutamate receptors causes a raise of [Ca
2+]i
in the third-order neurons.
Glutamate depolarizes the third-order neurons leading
to activation of voltage-gated Ca
2+ channels, therefore glu-
tamate-induced [Ca
2+]i could be the result of Ca
2+ influx
through both glutamate receptors and voltage-gated Ca
2+
channels. To separate [Ca
2+]i influx via glutamate recep-
tors from voltage-dependent Ca
2+ channels, 1mM cobalt
Figure 5 Glutamate induces Ca
2+ influx via both glutamate receptors and voltage-gated Ca
2+ channels in third-order neurons. (A)
Glutamate-induced [Ca
2+]i is completely blocked by ionotropic glutamate receptor antagonists, CNQX (50µM) and AP-7(40µM). (B) Co
2+ blocks
voltage-gated Ca
2+ channels, which reduces 55% of glutamate-induced [Ca
2+]i in the neurons (see asterisk); with Co
2+ taurine still suppresses
glutamate-induced [Ca
2+]i. (C) Ruthenium red (1µM), a rynadine receptor inhibitor, reduces 15% of glutamate-induced [Ca
2+]i; with ruthenium
red, taurine has 35% suppression on glutamate-induced [Ca
2+]i in the neurons. (D) Blocking Ca
2+ uptake pumps in the internal organelles with
thapsigargin (1µM) had a limited effect on taurine regulation of [Ca
2+]i.
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2+ channels. On aver-
age, cobalt reduced about 55% of the glutamate-induced
[Ca
2+]i (n=42, Fig. 5B, see asterisk). The remaining cobalt-
insensitive [Ca
2+]i was further suppressed by 2mM taurine,
indicating that taurine suppressed Ca
2+ influx through
ionotropic glutamate receptors.
Glutamate had a limited effect on triggering internal Ca
2+
release in isolated neurons
In many cases, Ca
2+ influx could stimulate Ca
2+ release
from the intracellular Ca
2+ stores. To assess the contribu-
tion of Ca
2+ release from internal stores, 1.5µM ruthe-
nium red was used to block ryanodine receptors in the
intracellular organelles, which blocked Ca
2+-sensitive
release from internal stores in the third-order neurons.
The effects of taurine on glutamate-induced Ca
2+
increase were examined in the control and with ruthe-
nium red. In the control, taurine suppressed 55% of glu-
tamate-induced [Ca
2+]i in the neurons, ruthenium red
approximately reduced 15% of glutamate-induced [Ca
2+]i
(Fig. 5C), glutamate had a limited effect on triggering rya-
nodine receptor -sensitive internal Ca
2+ release. With the
blockage of Ca
2+ release from internal stores, taurine
suppressed 35% of the total glutamate-induced [Ca
2+]i.
Since the taurine suppression was reduced in the pre-
sence of ruthenium red, this indicates that the effect of
taurine might reduce glutamate-induced internal Ca
2+
release via ryanodine receptors.
Another approach was to use thapsigargin to block the
Ca
2+-uptake pump in intracellular Ca
2+ release organelles
resulting in depletion of internal Ca
2+ release stores. The
same experimental protocol was applied for the control
and with the presence of 1.5µM thapsigargin. Figure 5D
demonstrates that thapsigargin pre-perfusion only caused
5% reduction of glutamate-induced [Ca
2+]i compared to
the control. Depleting internal Ca
2+ release stores had no
significant effect on taurine suppression of glutamate-
induced [Ca
2+]i . With thapsigargin, taurine still reduced
approximately 45% of glutamate-induced [Ca
2+]i similar
to the effect of taurine in control.
The above results confirm that Ca
2+ influx stimulated
internal Ca
2+ release played a minor role in glutamate-
induced [Ca
2+]i, therefore the major cause of glutamate-
induced [Ca
2+]i was Ca
2+ influx through receptors in
isolated neurons. Possibly, the effect of taurine was via
regulation of Ca
2+ permeability of glutamate receptors
and voltage-gated Ca
2+ channels.
Taurine regulation of glutamate-induced [Ca
2+]i was
sensitive to CaMKII and PKA inhibitors
If intracellular signal transduction pathways are involved
in taurine regulation, then their inhibitors should reverse
the suppressive potential of taurine. Several intracellular
protein inhibitors were used to block taurine produced
effect and among these inhibitors the selective cell-
permeable CaMKII inhibitor KN-62 and protein kinase A
inhibitor PKI (14-22) amide (both 1µM) could partially
reverse the taurine-produced suppressive effect on gluta-
mate responses. Figure 6A shows the statistics of the
reductions of glutamate-induced [Ca
2+]i by taurine in
Figure 6 Pharmacological evidence of CaMKII and PKA involved in taurine regulation of glutamate-induced [Ca
2+]i. (A) Statistical results
of the selective cell-permeable CaM kinase II inhibitor KN-62 and protein kinase A inhibitor PKI (14-22) amide (both 1µM) on taurine regulation
of glutamate-induced [Ca
2+]i in isolated third-order neurons. (B) CaMKII involved in the strychnine-insensitive taurine regulation on glutamate
response.
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In the control, taurine suppressed glutamate-induced
[Ca
2+]i. by 62%+3% (n=40). Application of KN-62 had no
effect on glutamate-induced [Ca
2+]i., however with
KN-62, taurine suppression was reversed significantly to
47%+3% (n=40, t=4.44, df=78, p<0.0001). In the case of
PKI (14-22) amide, taurine suppressed glutamate-induced
[Ca
2+]i by 63%+5% (n=38) in the control, which was
reduced to 52%+4% (t=1.99, df=74, p=0.0498) with block-
ade of PKA. This indicates that both CaMKII and PKA
are the intracellular proteins involved in the taurine sig-
naling transduction.
As shown in figure 3A the taurine suppression of glu-
tamate-induced [Ca
2+]i was via both the strychnine-sen-
sitive and -insensitive receptors, CaMKII and PKA and
could involve the downstream pathways of these taur-
ine-activated receptors. To specify which type of taur-
ine-activated receptors triggers the CaMKII-sensitive
regulation in glutamate-induced [Ca
2+]I,w ep e r f o r m e d
the experiments with strychnine to block strychnine-
sensitive taurine receptors, isolating strychnine-insensi-
tive taurine receptor response. Figure 6B is the statistical
results from 48 cells, showing that 2µM strychnine
blocked 67% of taurine-caused suppression on
glutamate-induced [Ca
2+]i. With strychnine, KN-62
further blocked about 11% of the taurine suppression on
glutamate-induced [Ca
2+]i (t=3.60, df=88, p=0.0005),
indicating that CaMKII mediates strychnine-insensitive
taurine regulation in the third-order neurons.
Evidence of Ca
2+ -dependent regulation of taurine
response
We found that while taurine regulates glutamate
response, Ca
2+ influx via glutamate receptors also regu-
lates taurine response. This was studied in a whole-cell
voltage-clamp recording mode. Taurine-elicited currents
were measured in the presence and absence of gluta-
mate receptor agonists. As the results in figure 2 show
that activation of AMPA and kainate receptors could
effectively raise [Ca
2+] levels, both 15µM AMPA and
kainate were used to elevate [Ca
2+]i levels in the neu-
rons. A taurine dose of 350µM was applied before the
application of AMPA or kainate. Taurine elicited a large
inward current with fast desensitization at a holding vol-
tage -70mV, and adding AMPA or kainate had no sig-
nificant change on the substandard taurine currents (the
left panels, Fig. 7A &7B). After pre-application of
AMPA and kainate however, the amplitudes of taurine
Figure 7 Taurine-elicited currents are suppressed by AMPA and kainate in isolated third-order neurons. (A and B) 350µM taurine elicits
currents that are suppressed by co-application of either 15µM AMPA or kainate; both amplitudes and kinetics of the taurine currents are altered
in the presence of AMPA or kainate. (C and D) the same experiments repeated with intracellular application of 10mM BAPTA.
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of the onset currents was much slower when compared
to the control (the right panels, Fig. 7A &7B). Although
15µM AMPA and kainate alone could elicit large [Ca
2+]i
increases (see Fig. 2B and 2C), the currents elicited by
these agonists were small at -70mV. Therefore, the
effect of AMPA and kainate on taurine-elicited currents
might be mainly caused by an increase in [Ca
2+]i levels,
rather than conductance change of the neurons.
To further identify that increasing [Ca
2+]i is the key
for altering taurine response, a fast Ca
2+ chelator
BAPTA was applied to buffer [Ca
2+]i in the micro-
domain regions under the plasma membranes of the
cells. BAPTA (10mM) was applied into the cytosol
through recording electrodes during whole-cell record-
ing. It was determined that BAPTA reduced the effects
of AMPA and kainate on taurine-elicited currents
(6 cells out of 8 recordings, Fig. 7C &7D). With BAPTA
buffer, both kinetics and amplitudes of taurine currents
increased suggesting that intracellular free Ca
2+ is a key
element for regulation of taurine currents by activation
of glutamate receptors in the third-order neurons.
Taken together, our study indicates that taurine and
glutamate reciprocally inhibit each other in the third-
order neurons. Figure 8 depicts the intracellular regula-
tion between taurine and glutamate, which summarizes
our findings. Taurine inhibits glutamate-induced [Ca
2+]i
via a CaMKII pathway. Meanwhile rapid a increase of
intracellular free Ca
2+ by activation of AMPA and kai-
nate receptors in turn negatively controls taurine
response in the retinal third-order neurons. However,
internal Ca
2+ release from the cellular organelles seemed
to be less effective in the intracellular regulation
pathways between taurine and glutamate in isolated
third-order neurons.
Discussion
Taurine and glutamate might be released from the same
cells
This study shows with specific antibody labeling that the
amphibian retina contains both taurine and taurine
transporter in photoreceptors and Off-type bipolar cells.
The presence of taurine in photoreceptors is consistent
with previous studies from mammalian and non-mam-
malian animals [11,19]. Taurine has been also reported
to present On-bipolar cells, amacrine and ganglion cells
in various species during development. In rat retina
taurine transporter has been observed in photoreceptors,
bipolar cells and Müller cells [7]. All these suggest that
in general taurine and glutamate are likely present in
the same neurons and possibly are released from the
same cells in retinas. However, no evidence suggests
that glutamate and taurine would co-release from same
vesicles.
It is unclear how taurine releases in the CNS. In reti-
nas both light stimulation and high potassium depolari-
zation increase extracellular levels of taurine, glutamate
and GABA [9,19-21]. This suggests that the mechanism
for taurine release might be similar to Ca
2+-dependent
release of glutamate and GABA. However, other
mechanisms might exist for taurine synaptic release in
neurons, for instance, taurine release from glutamatergic
cerebellar granule cells is Ca
2+-independent [22]. Hypos-
motic stimulation can also result in taurine release
[23-25]. These could be potential mechanisms for taur-
ine release in photoreceptors and Off-bipolar cells in
amphibian retina. Since taurine and the taurine trans-
porter are not present in Müller cells in the amphibian
retina, it is likely that taurine is released solely from
neurons in this species. Our study further demonstrates
that the synergistic release of taurine and glutamate pro-
vides reciprocal regulatory effects in the postsynaptic
neurons.
Pharmacology of taurine-produced effect in retinal third-
order neurons
Taurine has been shown to activate GABAA receptors in
rat hippocampal CA1 area [26] and interact with
GABAB binding sites in mouse brain [27]. The taurine
inhibitory effect is also sensitive to glycine receptor
antagonist strychnine, suggesting that taurine could be
acting through both GABA and glycine receptors [28].
Studies also suggest that taurine action on GABA and
glycine receptors is usually dependent on several factors,
such as concentration, specific region of the CNS and
animal age [29]. In this study we find that the 2mM
taurine-produced effect was partially blocked by
Figure 8 Potential intracellular pathways for reciprocal regulations
between taurine-sensitive receptor and glutamate receptor.
Bulley and Shen Journal of Biomedical Science 2010, 17(Suppl 1):S5
http://www.jbiomedsci.com/content/17/S1/S5
Page 12 of 15strychnine and picrotoxin, but not by any GABA recep-
tor antagonists. This finding is consistent with observa-
tions in isolated frog spinal cord [30]. If taurine has a
lower potency to GABA receptors than to glycine recep-
tors in the amphibian third-order neurons, the taurine
concentration used in this study might be too low to
activate GABA receptors since previous studies show
that in the 10µM and 1mM range taurine activates gly-
cine receptors while higher concentrations of taurine
(1mM-10mM) activate GABAA receptors in brain cells
[31-34]. The highest concentration of taurine we used is
on the low end of the GABA receptor activation but
based on the saturating concentration from whole-cell
recording (Fig. 1D). Molecular studies reveal that the
sensitivity of GABA receptors to taurine is also depen-
dent on receptor subunit compositions. Recombinant
GABAA receptor studies indicate that taurine is more
potent to GABAA receptors that consist of a, b, δ subu-
nits than those with a,b,g subunit combinations [3,35].
Possibly, GABAA receptors in amphibian third-order
neurons likely lack δ subunits, which results in a low
sensitivity of those receptors to taurine. By this nature,
we postulate that taurine release from Off-bipolar cells
may not significantly interfere with GABAergic inputs in
the third-order neurons. Taurine may be acting on
third-order neurons primarily through either glycine
receptor or a further unidentified taurine receptor [36]
that is sensitive to strychnine and picrotoxin. So far, it is
difficult to differentiate taurine-sensitive receptors from
glycine and GABA receptors or to study strychnine-
insensitive taurine response due to lack of pharmacolo-
gical tools. Also, there is no molecular evidence that
taurine has its own receptors.
Potential mechanisms involved in taurine regulation
Several findings are present in this study: 1) taurine reg-
ulates Ca
2+ permeable glutamate receptors via CaMKII-
and PKA-dependent intracellular pathways indicating
that the regulation is not due to blockage of glutamate
receptors by taurine. The result is in agreement with the
previous studies that taurine does not bind to any type
of glutamate receptor directly, including the glycine
binding site in NMDA receptor [43]. 2) Likely taurine
regulates glutamate induced Ca
2+ influx by either hyper-
polarizing the cell therefore reducing glutamate excita-
tion or by decreasing Ca
2+ permeability of glutamate
receptors via intracellular second messengers. Indeed,
taurine regulated glutamate response is dependent on
both strychnine-sensitive and -insensitive manners in
the third-order neurons (Fig. 3). The strychnine-sensi-
tive effect of taurine depicts an ionotropic effect that
suppresses glutamate excitation by hyperpolarizing the
cells to the Cl
- reversal potential that is more negative
than the resting membrane potential in the third-order
neurons, whereas the evidence of strychnine-insensitive
effect via a CaMKII-mediated intracellular pathway (Fig.
6) indicates that a metabotropic response of taurine
exists in the retinal third-order neurons. 3) Taurine reg-
ulations of L-, N and P/Q-type voltage-gated Ca
2+ chan-
nels, as well as Ca
2+-permeable NMDA receptors in
cultured brain neurons, have been reported previously
[45]. As consistent with the previous studies, our results
indicate that taurine reduces [Ca
2+]i accumulations in
the third-order neurons via not only Ca
2+ permeable
glutamate receptors, but voltage-gated Ca
2+ channels
since Co
2+ reduces a large amount [Ca
2+]i induced by
glutamate (Fig. 5B). Both NMDA and non-NMDA glu-
tamate receptors are Ca
2+ permeable in the amphibian
third-order neurons, which has been identified in pre-
vious studies [17,44]. We demonstrated that taurine reg-
ulate both Ca
2+-permeable glutamate receptors in the
neurons. 4) Ca
2+ is the second messenger for modula-
tion of taurine-sensitive receptors in the neurons. Gluta-
mate-induced accumulation of [Ca
2+]i could activate
both Ca
2+/calmodulin and PKA through a Ca
2+/calmo-
dulin-dependent mechanism. Also Ca
2+-dependent PKC
might be the mechanism for regulation of taurine-sensi-
tive receptors. The detail mechanism for Ca
2+ -related
regulation of taurine-sensitive receptors needs to be
further investigated.
The selective inhibitor of CaMKII has a significant
effect on taurine regulation and the PKA inhibitor
seems also to block taurine regulation to a smaller
extent. It is unclear whether these two cellular proteins
work in parallel or series pathways. Yao and Wu report
that Ca
2+ directly binds to Ca
2+/calmodulin to activate
CaMKII, then Ca
2+/calmodulin dependent activation of
adenylyl cyclase stimulates cAMP synthesis that in turn
activates PKA [37]. Since CaMKII can activate PKA, the
results with PKI (14-22) experiments suggest PKA
might be a down-stream protein of CaMKII pathway in
the taurine regulatory pathway. The CaMKII inhibitor
KN-62 was more effective at suppressing the taurine
effect possibly because it is further upstream in the sig-
nal transduction pathway. We also speculate whether
the CaMKII and PKA inhibitors directly suppress taur-
ine-sensitive receptors. This scenario could also cause a
reduction of the taurine suppression on glutamate-
induced [Ca
2+]i. Previous studies have indicated that
CaMKII modulates glycine and GABAA receptor activa-
tions by regulation of phosphorylation states [40-42].
Ca
2+-dependent regulations are involved in up-regula-
tion of taurine uptake [38] and taurine responses to
osmotic changes in neurons and astrocytes [39]. There-
fore, it is possible that CaMKII and PKA directly regu-
late taurine-sensitive receptors in the retinal neurons.
CaMKII-dependent regulations seem to be widely pre-
sented in taurine regulations in the CNS. In spite of
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also involved in taurine regulation, such as glutamate-
induced PKC that have also been shown to be down-
regulated by taurine [43]. Our study does not exclude
other pathways involved in taurine regulation of gluta-
mate response.
In general, activation of glutamate receptors leads to
an extracellular Ca
2+ influx as well as mobilization of
intracellular Ca
2+ stores [46]. However, in an isolated
cell preparation, we observed that internal Ca
2+ release
was much less sensitive to glutamate application. This
could be due to a depletion of internal Ca
2+ stores
caused by the process of enzyme-treatment and cell dis-
sociation. In these conditions, activation of metabotropic
glutamate receptors had very limited effect on stimulat-
ing internal Ca
2+ release since the release stores were
under depleted conditions. Therefore, our study did not
rule out the possibility that taurine regulation of meta-
botropic glutamate receptors in the third-order neurons
may also occur.
Possible functions of taurine in glutamate transmission
and neuroprotection
Taurine concentration in retinal tissues is extremely
high. Studies in goldfish retina show that the concentra-
tion of taurine is almost 20 times higher than that of
glutamate and as much as 25 times higher than GABA
[9]. Insufficient taurine in the embryonic stage of photo-
receptor development has been shown to lead to blind-
ness in newborns [25,50,51]. Supplementation of taurine
in the diet can reverse the damage caused in retinal
development by taurine deficiency [52]. Clearly, taurine
is important for retinal development and maturation.
Early studies have shown that taurine suppresses light-
evoked responses in Off-bipolar cells in mudpuppy reti-
n a sa sw e l la sl i g h t - e v o k e do f fr e s p o n s e si nt r a n s i e n t
ganglion cells in frog retinas [47-49]. Our results rein-
force the previous findings that taurine is a neurotrans-
mitter/modulator released from Off-bipolar cells to
directly activate amacrine and ganglion cells. The func-
tion of taurine regulation of Ca
2+ permeability in gluta-
mate receptors might relate to the control of glutamate
signals in the Off-pathway. In fact, taurine and gluta-
mate are reciprocally inhibiting each other. This sug-
gests that the regulation between glutamate and taurine
may contribute to fine-tuning light signals in the third-
order neurons.
Taurine has multiple functions in neuroprotection
against glutamate toxicity in the central brain [45,51,53].
Taurine has been shown to increase mitochondrial func-
tion of buffering [Ca
2+]i to protect cerebellar granule
cell damages in excitotoxicity [54]. Wu et al., (2009)
have reported that taurine can effectively reduce Ca
2+
overload via voltage-gated Ca
2+ channels and NMDA
glutamate receptors via intracellular calpain-dependent
mechanisms [45]. This leads to anti-apoptosis in brain
neurons. Indeed, taurine levels are increased after brain
ischemia and spinal cord injury in which neurons are
susceptible to the damage from glutamate toxicity [55].
This might indicate taurine as a natural neuroprotective
chemical in the CNS. Taurine inhibits glutamate-
induced [Ca
2+]i overloading might be the key function
for neuroprotection of taurine against cell damage by
excessive glutamate levels in pathological conditions.
The results from our study suggest that taurine might
have similar effects as in the central brain and spinal
cord to protect retinal neurons form glutamate toxicity
damage in disease.
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